Paradigm and Bristol Myers Squibb collaborate to build a new model for clinical trials

Paradigm collaborates with Bristol Myers Squibb to create a new clinical trial model, aiming to improve patient access, speed up results, and reduce provider burden. Starting with oncology, the initiative focuses on equitable enrollment and efficient trial operations, leveraging Paradigm's network and software to enhance clinical research accessibility and diversity.